CN Patent

CN103298796B — 2-(5-溴-4-(4-环丙基萘-1-基)-4h-1，2，4-三唑-3-基硫基)乙酸的多晶型形式及其用途

Assigned to Ardea Biociences Inc · Expires 2016-06-15 · 10y expired

What this patent protects

本发明阐述2-(5-溴-4-(4-环丙基萘-1-基)-4H-1，2，4-三唑3-基硫基)乙酸的结晶多晶型形式。本发明亦提供医药组合物及该等化合物、化合物形式及组合物用于治疗多种疾病及病状的用途。

USPTO Abstract

本发明阐述2-(5-溴-4-(4-环丙基萘-1-基)-4H-1，2，4-三唑3-基硫基)乙酸的结晶多晶型形式。本发明亦提供医药组合物及该等化合物、化合物形式及组合物用于治疗多种疾病及病状的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103298796B
Jurisdiction
CN
Classification
—
Expires
2016-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Ardea Biociences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.